In view of the Supreme Court's "long conference" on September 30th, it seems timely to review the arguments, pro, con, ...

Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...